From the Research
Screening for Newborns of Mothers with Gestational Diabetes Mellitus (GDM)
- Newborns of mothers with GDM are at increased risk of complications, including neonatal hypoglycemia, macrosomia, and respiratory distress 1, 2.
- Screening for these complications is essential to ensure proper management and care of the newborn.
- The following screenings should be considered for newborns of mothers with GDM:
Recommendations for Screening and Management
- The American College of Obstetricians and Gynecologists (ACOG) and other medical societies recommend screening for GDM at 24-28 weeks of gestation 3, 2.
- Women with risk factors, such as obesity and family history of diabetes, should be screened earlier and retested at 24-28 weeks if the initial test is negative 3.
- Newborns of mothers with GDM should be monitored closely for complications and managed accordingly 1, 2.
- Breastfeeding and lifestyle modifications can help reduce the risk of developing overt diabetes in women with GDM 3, 2.
Importance of Early Detection and Management
- Early detection and management of GDM can improve maternal and fetal outcomes 4, 5.
- Women with GDM are at increased risk of adverse obstetric and perinatal outcomes, but these complications can be prevented with early recognition, intense monitoring, and proper treatment 5.
- Screening for GDM and managing the condition can help reduce the risk of complications and improve outcomes for both mother and baby 4, 1, 3, 2, 5.